La IgE total como biomarcador de respuesta al omalizumab en la urticaria crónica: un estudio prospectivo

Levi Keller1, Jenny M Stitt1, Stephen C Dreskin1

  • 1Section of Allergy and Clinical Immunology, Division of Pulmonary Allergy and Critical Care Medicine, Department of Medicine, University of Colorado Denver School of Medicine, Aurora, CO.

Resumen

No abstract available in PubMed .